Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma.

[1]  Michael A. Gonzalez,et al.  Mcm‐2 and Ki‐67 Have Limited Potential in Preoperative Diagnosis of Thyroid Malignancy , 2006, The Laryngoscope.

[2]  M. Jelen,et al.  Mcm-2 protein expression predicts prognosis better than Ki-67 antigen in oral cavity squamocellular carcinoma. , 2006, Anticancer research.

[3]  M. Santoro,et al.  Mitogenic effects of the up-regulation of minichromosome maintenance proteins in anaplastic thyroid carcinoma. , 2005, The Journal of clinical endocrinology and metabolism.

[4]  S. Nordling,et al.  Prognostic Factors in Papillary Thyroid Cancer: An Evaluation of 601 Consecutive Patients , 2005, Tumor Biology.

[5]  Jin Woo Kim,et al.  Cancer-Associated Expression of Minichromosome Maintenance 3 Gene in Several Human Cancers and Its Involvement in Tumorigenesis , 2004, Clinical Cancer Research.

[6]  Michael A. Gonzalez,et al.  Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Takita,et al.  A new proliferation marker, minichromosome maintenance protein 2, is associated with tumor aggressiveness in esophageal squamous cell carcinoma , 2003, Journal of surgical oncology.

[8]  C. Larsson,et al.  MIB-1 index in thyroid tumors: a predictor of the clinical course in papillary thyroid carcinoma. , 2003, Thyroid : official journal of the American Thyroid Association.

[9]  K. Stoeber,et al.  Diagnosis of genito-urinary tract cancer by detection of minichromosome maintenance 5 protein in urine sediments. , 2002, Journal of the National Cancer Institute.

[10]  S. Fox,et al.  Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  G. Bepler,et al.  MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  D. Timler,et al.  Expression of proteins: D1 cyclin and Ki-67 in papillary thyroid carcinomas. , 2001, Folia histochemica et cytobiologica.

[13]  P. Hall,et al.  The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle , 2000, The Journal of pathology.

[14]  R. Laskey,et al.  The roles of the MCM, ORC, and Cdc6 proteins in determining the replication competence of chromatin in quiescent cells. , 2000, Journal of structural biology.

[15]  G. Williams,et al.  Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  B. Tye.  MCM proteins in DNA replication. , 1999, Annual review of biochemistry.

[17]  J. Arends,et al.  MIB-1 labelling index is an independent prognostic marker in primary breast cancer. , 1998, British Journal of Cancer.

[18]  B. Scheithauer,et al.  The prognostic significance of MIB‐1, p53, and DNA flow cytometry in completely resected primary meningiomas , 1998, Cancer.

[19]  R. Knippers,et al.  Stability of the replicative Mcm3 protein in proliferating and differentiating human cells. , 1998, Experimental cell research.

[20]  P. Wollan,et al.  Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[21]  M. Fujita,et al.  Immunolocalization of hCDC47 protein in normal and neoplastic human tissues and its relation to growth , 1997, International journal of cancer.

[22]  J. Blow,et al.  Cell cycle control of replication initiation in eukaryotes. , 1996, Current opinion in cell biology.

[23]  J. Richie,et al.  Expression of cell cycle-regulated proteins in prostate cancer. , 1996, Cancer research.

[24]  T. Oyama,et al.  Growth activity in hyperplastic and neoplastic human thyroid determined by an immunohistochemical staining procedure using monoclonal antibody MIB-1. , 1995, Human pathology.

[25]  E. Bergstralh,et al.  Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. , 1993, Surgery.

[26]  K. Lennert,et al.  Growth fractions in malignant non‐Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki‐67 , 1984, Hematological oncology.